1. MARKETS
  2. SECTOR : BANKING & FINANCE
  3. INDUSTRY : FINANCIAL CONGLOMERATES
  4. NEWGENIVF GROUP LTD - ORDINARY SHARES - CLASS A
NewGenIvf Group Ltd - Ordinary Shares - Class A
XNAS: NIVF
0.11-0.02(-15.38%)
29.2M

XNAS 05 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Board Meeting
The board meeting for NewGenIvf Grp Ltd (Class A) is scheduled for today, for the purpose of NewGenIvf Group Ltd Second Quarter Earnings Results for 2026See details

NewGenIvf Grp Ltd (Class A) quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

NewGenIvf Grp Ltd (Class A) quarterly results: revenue, profit, and P&L – 13 quarter history

  • POSITIVE

    Quarterly Revenue NewGenIvf Grp Ltd (Class A) Dec-2025 Quarterly Revenue is $1 Million which is growth of 11.9% YoY.

  • NEGATIVE

    Quarterly Net Profit NewGenIvf Grp Ltd (Class A) Dec-2025 Quarterly Net Profit is $-8 Million which is growth of -6985.1% YoY.

NewGenIvf Group Ltd - Ordinary Shares - Class A, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphDec '25Sep '25Jun '25Dec '24Sep '24Dec '23Sep '23Jun '23Mar '23Dec '22Sep '22Jun '22Mar '22
Operating Rev.
1.41.3-1.31.5
Cost Of Rev.
0.91.2-0.70.8--------
Gross Profit
0.50.1-0.50.7--------
⌄
5.52.6-1.60.41.30.40.40.50.10.10.10.2
Operating Profit
-5-2.5--1.10.2-1.3-0.4-0.4-0.5-0.1-0.1-0.1-0.2
-0.4-0.1--0.4-0.30.30.50.50.60.60.30.10
Profit Before Tax
-7.716.8--0.5-0-10.10.10.10.50.2-0-0.2
Tax
--0.5-
⌄
-7.716.8--0.1-0-10.10.10.10.50.2-0-0.2
Diluted NI Avail to Com Stockholders Ann.
-7.716.8--0.1-0-10.10.10.10.50.2-0-0.2
Basic EPS
-286.84,220.6--2,577.2-1,103.2-2.10.10.1-0.6-0.3-0.3-0-0.2
Diluted EPS After ExtraOrdinary
-286.84,220.6--71.3-9.8-2.10.10.1-0.6-0.3-0.3-0-0.2
Number Of Shares End
0-1.81.81.871.81.81.81.8
Net Income Continuing Discontinued Operations
-7.716.8--0.1-0-10.10.10.10.50.2-0-0.2
Normalized Income
-7.716.8--0.1-0-10.10.10.10.50.2-0-0.2
Interest Income
--00.30.50.50.60.60.30.10
Interest
0.40.1-0.40.2--------
Net Interest Income
-0.4-0.1--0.4-0.30.30.50.50.60.60.30.10
EBIT
-7.316.8--0.10.2-1.3-0.4-0.4-0.5-0.1-0.1-0.1-0.2
EBITDA
-7.316.8--0.10.2-1.3-0.4-0.4-0.5-0.1-0.1-0.1-0.2
Reconciled Cost Of Rev.
0.91.2-0.70.8--------
Reconciled Depr.
-------------
Profit From Continuing Operations
------10.10.10.10.50.2-0-0.2
Normalized EBITDA
-7.316.8--0.10.2-1.3-0.4-0.4-0.5-0.1-0.1-0.1-0.2
*All financials are in USD Million and price data in USD

NewGenIvf Grp Ltd (Class A) competitor comparison and performance snapshot within industry

NewGenIvf Grp Ltd (Class A) annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

  • NEGATIVE

    Annual Revenue NewGenIvf Grp Ltd (Class A) Dec-2025 Annual Revenue is $5 Million which is growth of -13.0% YoY.

  • POSITIVE

    Annual Net Profit NewGenIvf Grp Ltd (Class A) Dec-2025 Annual Net Profit is $10 Million which is growth of 1983.1% YoY.

NewGenIvf Group Ltd - Ordinary Shares - Class A, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21
-7.3%
 4.75.45.15.94.1
Cost Of Rev. Ann.
-4.8%
 3.83.63.54.43.1
Gross Profit Ann.
-12.6%
 11.81.71.51
Operating Exp. Ann.
119.9%
 11.731.61.10.8
Operating Profit Ann.
-
 -10.7-1.200.40.2
-
 -0.6-0.8-0.1-0.1-0.1
Other Exp. Ann.
-
 21.110.100.1
PBT Ann.
218.6%
 9.7-10.10.30.2
Tax Ann.
-
 -0.50.20.3
⌄
170.5%
 9.9-0.50.10.5
Diluted NI Avail to Com Stockholders Ann.
170.5%
 9.9-0.50.10.5
EPS Ann.
-75.6%
 369.4-12,491.57,232.925,481.5-29.6
Diluted EPS Ann.
-76.6%
 328.3-12,491.57,232.925,481.5-29.6
Number Of Shares End
-
 01.81.8-
Total Exp. Ann.
40.4%
 15.56.65.15.63.9
Net Income Continuing Discontinued Operations Ann.
170.5%
 9.9-0.50.10.5
Normalized Income Ann.
-
 -11.5-0.50.10.5
Interest Income Ann.
-
 0
Interest Ann.
81.7%
 0.60.80.10.10.1
EBITDA Ann.
148.9%
 10.800.40.70.6
Reconciled Cost Of Rev. Ann.
-4.8%
 3.83.63.54.43.1
Reconciled Depr. Ann.
18.6%
 0.50.20.20.30.3
Profit From Continuing Operations Ann.
359.5%
 9.7-0.50.10.1-0.1
Normalized EBITDA Ann.
-
 -10.600.40.70.6
*All financials are in USD Million and price data in USD
Total Rev. Ann.
1Y CHG
-13%
2Y CAGR
-4%
3Y CAGR
-7.3%
Net Profit Ann.
2Y CAGR
895%
3Y CAGR
170.5%
Operating Exp. Ann.
1Y CHG
290%
2Y CAGR
170.4%
3Y CAGR
119.9%

NewGenIvf Grp Ltd (Class A) balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

  • POSITIVE

    Total Shareholders Fund NewGenIvf Grp Ltd (Class A) Dec-2025 Total Shareholders Fund is $27 Million which is growth of 2639.7% YoY.

  • POSITIVE

    Total Assets NewGenIvf Grp Ltd (Class A) Dec-2025 Total Assets is $33 Million which is growth of 814.6% YoY.

NewGenIvf Group Ltd - Ordinary Shares - Class A, Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsDec '25Dec '24Dec '23Dec '22Dec '21
124.2%
32.73.61.72.91.4
⌄
33.8%
6.75.11.22.82.3
⌄
253.9%
26.6-1.10.90.6-0.8
Total Capitalization Ann.
271.2%
30.71.30.90.6-0.8
Tangible Assets Ann.
105.4%
5.2-1.10.90.6-0.8
Working Capital Ann.
-
50.50.1-0.2-1.3
Invested Capital Ann.
272.5%
311.90.90.6-0.3
Tangible Book Value Ann.
105.4%
5.2-1.10.90.6-0.8
Borrowings Ann.
114%
4.930.30.50.9
Net Debt Ann.
-
3.62.51.6-0.5
Share Issued Ann.
-
0
Number Of Shares End
-
01.81.8-
*All financials are in USD Million and price data in USD
Total Assets Ann.
1Y CHG
808.3%
2Y CAGR
338.6%
3Y CAGR
124.2%
Total Current Liabilities Ann.
1Y CHG
-11.1%
2Y CAGR
47.7%
3Y CAGR
-2.6%
Total ShareHolders Funds Ann.
2Y CAGR
443.7%
3Y CAGR
253.9%

NewGenIvf Grp Ltd (Class A) ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

  • POSITIVE

    Book Value Per Share NewGenIvf Grp Ltd (Class A) Book Value Per Share is $12 which is growth of 100.5% YoY.

  • NEUTRAL

    ROE NewGenIvf Grp Ltd (Class A) ROE is 0% which is growth of 0% YoY.

NewGenIvf Group Ltd - Ordinary Shares - Class A, Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsDec '25Dec '24Dec '23Dec '22Dec '21
RoA Ann. %
-
--20.08%5.72%21.25%-0.04%
ROE Ann. %
-
--17.84%1.47%-
ROIC %
-
---4.7-0.2-
OPM Ann. %
-
-226.95%-21.36%0.82%6.71%4.83%
Inventory Turnover Ratio Ann.
-
-34.839.999.975
Asset Turnover Ann. %
-
-2.12.32.82.9
Working Capital Turnover Ann.
-
0.91265-37.9-3.3
Quick Ratio Ann.
-
-0.710.90.4
Current Ratio Ann.
-
-1.21.10.90.4
Interest Coverage Ratio Ann.
-
--0.23.45.42.8
LT Debt To Equity Ann.
-
--0.10.4-
*All financials are in USD Million and price data in USD

NewGenIvf Grp Ltd (Class A) cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

  • NEGATIVE

    Cash From Operating Activity NewGenIvf Grp Ltd (Class A) Dec-2025 Cash From Operating Activity is $-11 Million which is growth of -32.2% YoY.

  • POSITIVE

    Net Cash Flow NewGenIvf Grp Ltd (Class A) Dec-2025 Net Cash Flow is $1 Million which is growth of 41.3% YoY.

NewGenIvf Group Ltd - Ordinary Shares - Class A, Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsDec '25Dec '24Dec '23Dec '22Dec '21
-
-10.9-8.3-1.81.71.4
-
-7.6-0.1-0.1-0.1-0
-
198.71.9-1.6-1.5
Cash Plus Cash Eqv. End Of Year Ann.
-
0.80.50.100
Net Increase In Cash Plus Cash Eqv.s Ann.
-
0.50.40.1-0-0.1
Cash Plus Cash Eqv. Begin Of Year Ann.
-
0.50.1000.1
Income Tax Paid Supplemental Data Ann.
-
0
Interest Paid Supplemental Data Ann.
-
00.800.10.1
Capex Ann.
-
-5.8-0.1-0.1-0.1-0
Issuance Of Capital Stock Ann.
-43.3%
12.60.269
Issuance Of Debt Ann.
183%
6.88.61.60.3-
Repayment Of Debt Ann.
-
-0.5-0-0-0-0
Repurchase Of Capital Stock Ann.
-
---52--
Free Cash Flow Ann.
-
-16.7-8.3-1.81.61.4
*All financials are in USD Million and price data in USD
Cash from Financing Act. Ann.
1Y CHG
118.4%
2Y CAGR
216.2%